This paper is in the following e-collection/theme issue:

Telepsychiatry (147) JMIR Theme Issue: COVID-19 Special Issue (2394) Telehealth and Telemonitoring (1575) Outbreak and Pandemic Preparedness and Management (1679) JMH Theme Issue: COVID-19 and Mental Health: Impact and Interventions (374) Substance Abuse (383)

Published on in Vol 8, No 2 (2021): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25835, first published .
Use of Telehealth in Substance Use Disorder Services During and After COVID-19: Online Survey Study

Use of Telehealth in Substance Use Disorder Services During and After COVID-19: Online Survey Study

Use of Telehealth in Substance Use Disorder Services During and After COVID-19: Online Survey Study

Authors of this article:

Todd Molfenter1 Author Orcid Image ;   Nancy Roget2 Author Orcid Image ;   Michael Chaple3 Author Orcid Image ;   Stephanie Behlman1 Author Orcid Image ;   Olivia Cody1 Author Orcid Image ;   Bryan Hartzler4 Author Orcid Image ;   Edward Johnson5 Author Orcid Image ;   Maureen Nichols6 Author Orcid Image ;   Patricia Stilen7 Author Orcid Image ;   Sara Becker8 Author Orcid Image
Article Authors Cited by (61) Tweetations (9) Metrics

Journals

  1. O'Callaghan D, Lambert S. The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction. Journal of Substance Abuse Treatment 2022;138:108720 View
  2. Kisicki A, Becker S, Chaple M, Gustafson D, Hartzler B, Jacobson N, Murphy A, Tapscott S, Molfenter T. Behavioral healthcare organizations’ experiences related to use of telehealth as a result of the COVID-19 pandemic: an exploratory study. BMC Health Services Research 2022;22(1) View
  3. Beck A, Larance B, Baker A, Deane F, Manning V, Hides L, Kelly P. Supporting people affected by problematic alcohol, substance use and other behaviours under pandemic conditions: A pragmatic evaluation of how SMART recovery Australia responded to COVID-19. Addictive Behaviors 2023;139:107577 View
  4. Gliske K, Welsh J, Braughton J, Waller L, Ngo Q. Telehealth Services for Substance Use Disorders During the COVID-19 Pandemic: Longitudinal Assessment of Intensive Outpatient Programming and Data Collection Practices. JMIR Mental Health 2022;9(3):e36263 View
  5. Galvin E, Desselle S, Gavin B, Quigley E, Flear M, Kilbride K, McNicholas F, Cullinan S, Hayden J. Implementation of telemedicine consultations for people with mental health conditions in the community: a protocol for a systematic review. HRB Open Research 2022;4:125 View
  6. Meshberg‐Cohen S, Farook M, Gross G, Levina V, DeViva J. Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic. The American Journal on Addictions 2023;32(1):32 View
  7. Langdon K, Jiménez Muñoz P, Block A, Scherzer C, Ramsey S. Feasibility and Acceptability of a Digital Health Intervention to Promote Continued Engagement in Medication for Opioid Use Disorder Following Release From Jail/Prison. Substance Abuse: Research and Treatment 2022;16:117822182211271 View
  8. Amin R, Hossain M, Uddin M, Jony M, Kim M. Stimuli Influencing Engagement, Satisfaction, and Intention to Use Telemedicine Services: An Integrative Model. Healthcare 2022;10(7):1327 View
  9. Priescu I, Oncioiu I. Measuring the Impact of Virtual Communities on the Intention to Use Telemedicine Services. Healthcare 2022;10(9):1685 View
  10. Rouidi M, Elouadi A, Hamdoune A. Acceptance and use of telemedicine technology by health professionals: Development of a conceptual model. DIGITAL HEALTH 2022;8:205520762210816 View
  11. Bradley H, Austin C, Allen S, Asher A, Bartholomew T, Board A, Borquez A, Buchacz K, Carter A, Cooper H, Feinberg J, Furukawa N, Genberg B, Gorbach P, Hagan H, Huriaux E, Hurley H, Luisi N, Martin N, Rosenberg E, Strathdee S, Jarlais D. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic. International Journal of Drug Policy 2022;110:103889 View
  12. Hubach R, O'Neil A, Ernst C, Stowe M, Hickey M, Remondino M, Giano Z. Client perspectives on the accessibility and quality of substance use treatment during the COVID-19 pandemic. Drug and Alcohol Dependence Reports 2021;1:100002 View
  13. Meanley S, Choi S, Thompson A, Meyers J, D’Souza G, Adimora A, Mimiaga M, Kempf M, Konkle-Parker D, Cohen M, Teplin L, Murchison L, Rubin L, Rubtsova A, Weiss D, Aouizerat B, Friedman M, Plankey M, Wilson T. Short-term binge drinking, marijuana, and recreational drug use trajectories in a prospective cohort of people living with HIV at the start of COVID-19 mitigation efforts in the United States. Drug and Alcohol Dependence 2022;231:109233 View
  14. Guillen A, Reddy M, Saadat S, Chakravarthy B. Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review. Telemedicine and e-Health 2021 View
  15. Lin C, Pham H, Zhu Y, Clingan S, Lin L, Murphy S, Campbell C, Sorrell T, Liu Y, Mooney L, Hser Y. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug and Alcohol Dependence 2023;242:109711 View
  16. Shapira B, Rosca P. Transformation of substance use disorder treatment services during COVID-19 - A lasting change?. Journal of Substance Use 2023;28(4):552 View
  17. Walters S, Perlman D, Guarino H, Mateu-Gelabert P, Frank D. Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities. Substance Use & Misuse 2022;57(7):1144 View
  18. Kumar N, Janmohamed K, Nyhan K, Martins S, Cerda M, Hasin D, Scott J, Sarpong Frimpong A, Pates R, Ghandour L, Wazaify M, Khoshnood K. Substance, use in relation to COVID-19: A scoping review. Addictive Behaviors 2022;127:107213 View
  19. Shircliff K, Liu M, Prestigiacomo C, Fry M, Ladd K, Gilbert M, Rattermann M, Cyders M, Carrà G. Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder. PLOS ONE 2022;17(7):e0270582 View
  20. Caballeria E, López-Pelayo H, Matrai S, Gual A. Telemedicine in the treatment of addictions. Current Opinion in Psychiatry 2022;35(4):227 View
  21. Walters J, Jones A, Brown A, Wallis D. Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program. International Journal of Environmental Research and Public Health 2022;19(18):11164 View
  22. Parker D, Zentner D, Burack J, Wendt D. The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review. Drugs: Education, Prevention and Policy 2023;30(6):529 View
  23. Sung M, Black A, Blevins D, Henry B, Cates-Wessel K, Dawes M, Drexler K, Hagle H, Molfenter T, Levin F, Becker W, Edelman E. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of Addiction Medicine 2022;16(5):505 View
  24. Gainer D, Wong C, Embree J, Sardesh N, Amin A, Lester N. Effects of Telehealth on Dropout and Retention in Care among Treatment-Seeking Individuals with Substance Use Disorder: A Retrospective Cohort Study. Substance Use & Misuse 2023;58(4):481 View
  25. Yamada C, Siste K, Hanafi E, Ophinni Y, Beatrice E, Rafelia V, Alison P, Limawan A, Shinozaki T, Matsumoto T, Sakamoto R. Relapse prevention group therapy via video-conferencing for substance use disorder: protocol for a multicentre randomised controlled trial in Indonesia. BMJ Open 2021;11(9):e050259 View
  26. Barwise A, Huschka T, Woo C, Egginton J, Huang L, Allen J, Johnson M, Hamm K, Wolfersteig W, Phelan S, Allyse M. Perceptions and Use of Telehealth Among Diverse Communities: Multisite Community-Engaged Mixed Methods Study. Journal of Medical Internet Research 2023;25:e44242 View
  27. Galvin E, Desselle S, Gavin B, Quigley E, Flear M, Kilbride K, McNicholas F, Cullinan S, Hayden J. Implementation of telemedicine consultations for people with mental health conditions in the community: a protocol for a systematic review. HRB Open Research 2022;4:125 View
  28. Becker S, Kisicki A, Chaple M, Freese T, Gotham H, Greller R, Hagle H, Henry M, Krom L, Martin R, Powell K, Roget N, Velez-Echevarria I, Yáñez R, Molfenter T. Providing behavioral workforce development technical assistance during COVID-19: adjustments and needs. Translational Behavioral Medicine 2022;12(1) View
  29. Galvin E, Desselle S, Gavin B, Quigley E, Flear M, Kilbride K, McNicholas F, Cullinan S, Hayden J. Implementation of telemedicine consultations for people with mental health conditions in the community: a protocol for a systematic review. HRB Open Research 2021;4:125 View
  30. Rouidi M, Elouadi A, Hamdoune A, Choujtani K, Chati A. TAM-UTAUT and the acceptance of remote healthcare technologies by healthcare professionals: A systematic review. Informatics in Medicine Unlocked 2022;32:101008 View
  31. Hartzler B, Gray K, Marx M, Kirk-Lewis K, Payne-Smith K, McIlveen J. Community implementation of contingency management to address stimulant use. Journal of Substance Use and Addiction Treatment 2023;151:208941 View
  32. Poulsen M, Santoro W, Scotti R, Henderson C, Ruddy M, Colistra A. Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19. Journal of Addiction Medicine 2023;17(2):e110 View
  33. McCuistian C, Fokuo J, Dumoit Smith J, Sorensen J, Arnold E. Ethical Dilemmas Facing Substance Use Counselors During the COVID-19 Pandemic. Substance Abuse: Research and Treatment 2023;17:117822182311583 View
  34. Carlyle M, Newland G, Morris L, Ellem R, Tisdale C, Quinn C, Hides L. A Longitudinal Assessment of Substance Use Treatment during the COVID-19 Pandemic Using Staff and Service Data. BioMed 2023;3(2):217 View
  35. Fast N, van Kessel R, Humphreys K, Ward N, Roman-Urrestarazu A. The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review. Current Addiction Reports 2023;10(2):187 View
  36. Tomlinson M, McCann-Pineo M, Thomas M, Polydorou S. Demographic differences in services utilization across in-person (2019), telehealth (2020), and hybrid (2021) outpatient substance use services in New York. Journal of Substance Use and Addiction Treatment 2023;150:209047 View
  37. Liu M, Richard L, Campitelli M, Nisenbaum R, Dosani N, Dhalla I, Wadhera R, Shariff S, Hwang S. Drug Overdoses During the COVID‐19 Pandemic Among Recently Homeless Individuals. Addiction 2022;117(6):1692 View
  38. Beck A, Waks S, Argent A, Deane F, Larance B, Manning V, Baker A, Hides L, Kelly P. The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives. International Journal of Drug Policy 2023;120:104174 View
  39. de Beurs E, Rademacher C, Blankers M, Peen J, Dekker J, Goudriaan A. Alcohol use disorder treatment via video conferencing compared with in‐person therapy during COVID‐19 social distancing : A non‐inferiority comparison of three cohorts. Alcohol: Clinical and Experimental Research 2023;47(11):2208 View
  40. Pham H, Lin C, Zhu Y, Clingan S, Lin L, Mooney L, Murphy S, Campbell C, Liu Y, Hser Y. Telemedicine-delivered treatment for substance use disorder: A scoping review. Journal of Telemedicine and Telecare 2023 View
  41. Levine E, Sugarman D, Rockas M, McHugh R, Jordan C, Greenfield S. Alcohol Treatment Access and Engagement Among Women in the USA: a Targeted Review of the Literature 2012–2022. Current Addiction Reports 2023;10(4):638 View
  42. Oblath R, Twohy E, Higdon C, Duncan A, Folk J, Schiel M, Grewal S, Hawks J, Martinez W, Coble K, Edwards S, Goetz A, Ramtekkar U, Kulkarni C, Khan S, Doan B, Nallapula K, Fornari V, Fortuna L, Myers K. The Provision and Utilization of Telehealth Within Academic Mental Health Clinics in North America During the COVID-19 Pandemic. JAACAP Open 2023;1(3):218 View
  43. Krawczyk N, Rivera B, King C, Dooling B. Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States. Health Affairs Scholar 2023;1(1) View
  44. Elison-Davies S, Pittard L, Myton T, Jones A, Ward J, Davies G. Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel group randomized controlled trial. Addiction Science & Clinical Practice 2023;18(1) View
  45. Baloh J, Charton H, Curran G. Substance Use Disorder Treatment Programs during a Health Crisis: Response to the COVID-19 Pandemic and Future Implications. Substance Use & Misuse 2023;58(14):1855 View
  46. Dominiak M, Gędek A, Antosik A, Mierzejewski P. Prevalence, attitudes and concerns toward telepsychiatry and mobile health self-management tools among patients with mental disorders during and after the COVID-19 pandemic: a nationwide survey in Poland from 2020 to 2023. Frontiers in Psychiatry 2024;14 View
  47. Elliott K, Nabulsi E, Sims-Rhodes N, Dubre V, Barena E, Yuen N, Morris M, Sass S, Kennedy B, Singh K. Modality and terminology changes for behavioral health service delivery during the COVID-19 pandemic: a systematic review. Frontiers in Psychiatry 2024;14 View
  48. Dominiak M, Gędek A, Antosik A, Mierzejewski P. Mobile health for mental health support: a survey of attitudes and concerns among mental health professionals in Poland over the period 2020-2023. Frontiers in Psychiatry 2024;15 View
  49. Walton M, Kang A, DelaCuesta C, Hoadley A, Martin R. Old tech but not low tech: telephone-based treatment provision for substance use. Frontiers in Psychiatry 2024;15 View
  50. Perumalswami P, Adams M, Frost M, Holleman R, Kim H, Zhang L, Lin L. Telehealth and delivery of alcohol use disorder treatment in the Veterans Health Administration. Alcohol, Clinical and Experimental Research 2024;48(5):944 View
  51. Hatch M, Laschober T, Ertl M, Paschen-Wolff M, Norman G, Wright L, Tross S. Program Director Reports of COVID-19 Lockdown-Driven Service Changes in Community-Based STI Clinics and Syringe Services Programs in the Southeastern U.S.. AIDS Education and Prevention 2024;36(2):129 View
  52. Kaufman M, Zhou X, Yenokyan G, Levine D, Wright K, Salcido M, Garringer M, Palen L. Exploring organizational digital readiness to offer youth E-Mentoring. Mentoring & Tutoring: Partnership in Learning 2024;32(4):361 View
  53. Siste K, Ophinni Y, Hanafi E, Yamada C, Novalino R, Limawan A, Beatrice E, Rafelia V, Alison P, Matsumoto T, Sakamoto R. Relapse Prevention Group Therapy in Indonesia Involving Peers via Videoconferencing for Substance Use Disorder: Development and Feasibility Study. JMIR Formative Research 2024;8:e50452 View
  54. Hadinata I, Naren T, Rowland B, Cook J, Nielsen S. Do video or telephone consultations impact attendance rates in an addiction medicine specialist outpatient clinic?. Internal Medicine Journal 2024 View
  55. Ndulue O, Naslund J. Digital interventions for alcohol use disorders: A narrative review of opportunities to advance prevention, treatment and recovery. Psychiatry Research Communications 2024:100183 View

Books/Policy Documents

  1. Hagle H, Liu Y, Murphy D, Krom L. Handbook of Research on Updating and Innovating Health Professions Education. View
  2. Shapira B, Neumark Y. Handbook of Substance Misuse and Addictions. View
  3. Shapira B, Neumark Y. Handbook of Substance Misuse and Addictions. View
  4. Beiglböck W, Preinsperger W. Suchtbehandlung und Digitalisierung. View
  5. LaGrotta C, Collins C. Technology-Assisted Interventions for Substance Use Disorders. View
  6. Fruitman K. Technology-Assisted Interventions for Substance Use Disorders. View